Wells Fargo’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-13
| Closed | -$35 | – | 7439 |
|
|
2023
Q1 | $35 | Buy |
13
+9
| +225% | +$24 | ﹤0.01% | 6886 |
|
|
2022
Q4 | $16 | Hold |
4
| – | – | ﹤0.01% | 7004 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 7493 |
|
|
2022
Q2 | $0 | Buy |
4
+1
| +33% | – | ﹤0.01% | 7559 |
|
|
2022
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 7603 |
|
|
2021
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 7553 |
|
|
2021
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 7424 |
|
|
2021
Q2 | $0 | Buy |
3
+1
| +50% | – | ﹤0.01% | 7308 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 7203 |
|
|
2020
Q4 | $0 | Sell |
2
-11
| -85% | – | ﹤0.01% | 6897 |
|
|
2020
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 5890 |
|
|
2020
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 5820 |
|
|
2020
Q1 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 5768 |
|
|
2019
Q1 | – | Sell |
-14
| Closed | -$7K | – | 6199 |
|
|
2018
Q4 | $7K | Buy |
+14
| New | +$7K | ﹤0.01% | 5628 |
|
|
2018
Q3 | – | Sell |
-14
| Closed | -$8K | – | 6123 |
|
|
2018
Q2 | $8K | Buy |
+14
| New | +$8K | ﹤0.01% | 5653 |
|